Sorcero
Sorcero is on a mission to improve patient outcomes by empowering life sciences experts.
Empowering Customer Engagement with Artificial Intelligence
The real value of AI is reaped when complex data is transformed into clear, easy-to-understand recommendations that are surfaced at the point of execution.
Veeva Systems Inc.
Our industry cloud solutions provide data, software, services, and an extensive ecosystem of partners to support your most critical medical affairs functions. Veeva helps companies of all sizes bring products to market faster and more efficiently while maintaining compliance.
VML Health
We combine the best of technology with the best of medicine to create amazing enterprise software platforms to support your interactions and engagements with HCPs and KOLs.
Our platforms support the entire HCP operational lifecycle: mapping, planning, engagement, insights, contract-to-pay, and much more.
WHITE PAPER: Communicating the Value of Independent Medical Education to Key Stakeholders
Pharmaceutical teams need a different way to approach working virtually. The secret isn’t adding more virtual calls, but unlocking the strategic power of virtual work. Download this white paper to see how your peers are achieving more, with fewer meetings.
Medical Affairs Insights: A Glossary of Terms
MAPS Insights Focus Area Working Group (FAWG) members define some of the terms associated with the collection and use of insights as a way to start standardizing the lexicon of the function.
Unlocking the Secrets of Virtual Work | WHITE PAPER
Pharmaceutical teams need a different way to approach working virtually. The secret isn’t adding more virtual calls, but unlocking the strategic power of virtual work. Download this white paper to see how your peers are achieving more, with fewer meetings.
Janssen Pharmaceuticals Joins Medical Affairs Professional Society (MAPS) Industry Partnership Program
The Medical Affairs Professional Society (MAPS) is honored to announce the inclusion of Johnson and Johnson Pharmaceuticals (JNJ) in the MAPS Industry Partnership Program
What can we learn from 2 insight surveys of MAPS membership?
This paper provides a brief overview of the results of two MAPS insight surveys as well as suggested next steps to develop a common framework that biopharma companies can use to achieve a more consistent and effective approach to generating medical insights as a principal driver for strategy shaping and choice of tactics.